Form D · Biotechnology
Gusto Global, LLC
Morrisville, NC · CIK 0001725023
Offering snapshot reported Sep 21, 2022 · SEC filing
- Reported sold
- $1.85M Offering amount: $1.85M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 14, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 21, 2022 | Initial | $1,850,000 | No comparison | 2 | SEC filing |
| May 28, 2021 | Initial | $300,000 | No comparison | 8 | SEC filing |
| Jun 24, 2019 | Initial | $400,000 | No comparison | 1 | SEC filing |
| Dec 22, 2017 | Initial | $3,000,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-459491
Source: Form D, filed Sep 21, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Clark Fennebresque, Jr. | Executive |
| Mark Spizer | Executive |
| Daniel Van Der Lelie | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
400 Park Offices Drive Suite 104
Morrisville, NC, 27560
Morrisville, NC, 27560